CSPC Innovation Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 300765.SZ

CSPC Innovation Pharmaceutical Co., Ltd. Total Non-Current Liabilities for the year ending December 31, 2023: USD 4.81 M

CSPC Innovation Pharmaceutical Co., Ltd. Total Non-Current Liabilities is USD 4.81 M for the year ending December 31, 2023, a -41.89% change year over year. Total non-current liabilities are the sum of long-term debt and other non-current liabilities.

CSPC Innovation Pharmaceutical Co., Ltd. Total Non-Current Liabilities for the year ending December 31, 2022 was USD 8.27 M, a 52.78% change year over year.
CSPC Innovation Pharmaceutical Co., Ltd. Total Non-Current Liabilities for the year ending December 31, 2021 was USD 5.41 M, a 4.66% change year over year.
CSPC Innovation Pharmaceutical Co., Ltd. Total Non-Current Liabilities for the year ending December 31, 2020 was USD 5.17 M, a -0.79% change year over year.
CSPC Innovation Pharmaceutical Co., Ltd. Total Non-Current Liabilities for the year ending December 31, 2019 was USD 5.21 M, a -14.85% change year over year.

Key data

Date	Total Non-Current Liabilities	Shareholders' Equity	Other Liabilities	Total Liabilities

Shenzhen Stock Exchange: 300765.SZ

CSPC Innovation Pharmaceutical Co., Ltd.

CEO	Mr. Feng Han
IPO Date	March 22, 2019
Location	China
Headquarters	No. 36, Fuqiang Western Road
Employees	1,887
Sector	Consumers Staples
Industries Non-Alcoholic Beverages Alcoholic Beverages Consumer Packaged Goods Drugstores & Retail Pharmacies Pharmaceuticals Soft Drinks & Sodas Tobacco

Description

CSPC Innovation Pharmaceutical Co., Ltd. manufactures and sells caffeine, and vitamin C health supplement and beverage products. The company is based in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC Pharmaceutical Group Limited.

Key trends

Past 5 years